Effects of SolCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model

Journal of Thrombosis and Thrombolysis

Volumn 19, Issue 2, 2005, Pages 115-122

  Buergler, John M ^a   Maliszewski, Charles R ^b   Broekman, M Johan ^c   Kaluza, Grzegorz L ^a   Schulz, Daryl G ^a   Marcus, Aaron J ^c   Raizner, Albert E ^a   Kleiman, Neal S ^a   Ali, Nadir M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b AMGEN INC   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ADP; Balloon angioplasty; Nucleotidases; Platelet activation; Platelets; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; COLLAGEN; FIBRIN; RECOMBINANT SOLUBLE FORM OF CD39; SOLCD39; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TICLOPIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; BLOOD CLOT RETRACTION; CONCENTRATION RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG TOLERABILITY; EX VIVO STUDY; FIBRIN DEPOSITION; HUMAN; HUMAN CELL; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SWINE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTIGENS, CD; APYRASE; BLOOD COAGULATION TESTS; COLLAGEN; DRUG EVALUATION, PRECLINICAL; HALF-LIFE; HUMANS; MODELS, ANIMAL; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, THROMBIN; SOLUBILITY; SWINE;

EID: 23644432791     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-005-1381-y     Document Type: Article

References (23)

1. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983-989. 3531859
2. AJ Marcus 1999 Platelets: Their role in hemostasis, thrombosis, and inflammation In: JI Gallin R Snyderman eds. Inflammation: Basic Principles and Clinical Correlates Lippincott Williams and Wilkins Philadelphia, PA 77-95
3. Marcus AJ, Safier LB, Hajjar KA, et al. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 1991;88:1690-1696. 1939654
4. Marcus AJ, Broekman MJ, Drosopoulos JH, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997;99:1351-1360. 9077545
5. Kansas GS, Wood GS, Tedder TF. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol 1991;146:2235-2244. 1672348
6. Ling NR, Hardie D, Lowe J, Johnson GD, Khan M, MacLennan IC. A phenotypic study of cells from Burkitt lymphoma and EBV-B- lymphoblastoid lines and their relationship to cells in normal lymphoid tissues. Int J Cancer 1989;43:112-118. 2536003
7. Rowe M, Hildreth JE, Rickinson AB, Epstein MA. Monoclonal antibodies to Epstein-Barr virus-induced, transformation- associated cell surface antigens: Binding patterns and effect upon virus-specific T-cell cytotoxicity. Int J Cancer 1982;29:373-381. 6282762
8. Gayle RB, Maliszewski CR, Gimpel SD, et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 1998;101:1851-1859. 9576748
9. Mertz ET. The anomaly of a normal Duke's and a very prolonged saline bleeding time in swine suffering from an inherited bleeding disease. Am J Physiol 1942;136:360-362.
10. Doettl K, Ripke O. Medicine in its Chemical Aspects. Bayer, Leverkusen, Germany, 1938:252.
11. Bowie EJ, Owen CA, Zollman PE, Zollman PE, Thompson JH, Fass DN. Tests of hemostasis in swine: Normal values and values in pigs affected with von Willebrand's disease. Am J Vet Res 1973;34:1405-1407. 4542959
12. Dewanjee MK, Rao SA, Didisheim P. Indium-111 tropolone, a new high-affinity platelet label: Preparation and evaluation of labeling parameters. J Nucl Med 1981;22:981-987. 7299484
13. Dewanjee MK, Tago M, Josa M, Fuster V, Kaye MP. Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin. Circulation 1984;69:350-356. 6606504
14. Pinsky DJ, Broekman MJ, Peschon JJ, et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 2002;109:1031-1040. 10.1172/JCI200210649
15. Drosopoulos JH, Broekman MJ, Islam N, Maliszewski CR, Gayle RB 3rd, Marcus AJ. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: Requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment. Biochemistry 2000;39:6936-6943. 10.1021/bi992581e
16. Gangadharan SP, Imai M, Rhynhart KK, Sevigny J, Robson SC, Conte MS. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries. Surgery 2001;130:296-303. 10.1067/msy.2001.116032
17. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH, Investigators FT, Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-629. 10931801
18. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-533. 10.1016/S0140-6736(01)05701-4
19. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001;86:222-232. 11487010
20. Turner NA, Moake JL, McIntire LV. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. Blood 2001;98:3340-3345. 10.1182/ blood.V98.12.3340
21. Imai M, Takigami K, Guckelberger O, et al. Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 2000;70:864-870. 10.1097/00007890-200009270-00003
22. Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, Robson SC. CD39 modulates endothelial cell activation and apoptosis. Mol Med 2000;6:591-603. 10997340
23. Sesti C, Broekman MJ, Drosopoulos JH, Islam N, Marcus AJ, Levi R. EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. J Pharmacol Exp Ther 2002;300:605-611. 10.1124/jpet.300.2.605